| Name | Title | Contact Details |
|---|
BehavioSec is a behavioral biometrics company providing continuous authentication for end users based on their interactions with web and mobile apps.
Desde 1997 somos una empresa de diseño web en Barcelona, programación web, usabilidad y posicionamiento Proyectos prácticos y rentables que se adaptan a ...
We didn`t invent the Internet. But it`s going to feel like we did. When you`re fundamentally rethinking WiFi, you need a very special group of people. Much of the tech we use every day wouldn`t work at all if it wasn`t for some of our team members. We helped bring broadband to our homes over fiber-optic networks. We put WiFi chips into billions of devices. And today, we have a new mission - reinventing home WiFi.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.